Vitamin D3 reduces hippocampal NR2A and anxiety in nicotine withdrawal mice
Bingxue Wu,Xinrong Tao,Chuanlin Liu,Huaixu Li,Tao Jiang,Zijun Chen,Qi Wang,Fei Liu,Min Mu,Zhaoyan Chen
DOI: https://doi.org/10.1515/tnsci-2020-0166
2021-01-01
Translational Neuroscience
Abstract:Nicotine withdrawal symptoms, mainly anxiety, cause high level of relapse rate after quitting smoking. Vitamin D supplementation has shown its potential for the prevention and treatment of anxiety disorders; how-ever, neurobiological studies about the effect of vitamin D on nicotine withdrawal-induced anxiety are limited. To investigate the effect and molecular mechanism of vitamin D3 supplement by dietary on anxiety-like behavior during nicotine withdrawal, male C57/BL6 mice were divided into four groups: vehicle, nicotine only, vitamin D3 only, and nicotine plus vitamin D3. Mice were administrated with nicotine in drinking water (200 mu g/mL), and vitamin D3 in feed for 6 weeks. During nicotine withdrawal, vitamin D3-treated mice showed significantly less anxiety-like behavior by an open-field test and marble buried test that performed an increase in the duration of the central zone and a decrease buried marble, respectively. Moreover, vitamin D3 supplementation attenuated the hippocampal NR2A expression on both protein and mRNA levels in nico-tine and vitamin D3-treated mice. Our data showed that dietary supplementation with vitamin D3 ameliorated nico-tine withdrawal-induced anxiety, which may be related to downregulation of NR2A expression in hippocampus. Vitamin D3 may provide a new dietary intervention with the easy access for smoking cessation.
What problem does this paper attempt to address?